Eli Lilly LLY
NYSE LLY
$1,437.76 +5.46 (+0.38%)
At close: Nov 11, 2026 · 4:00 PM EST

Eli Lilly (LLY) Current Deferred Tax Assets (2009 - 2010)

Updated

Eli Lilly (LLY) reported Current Deferred Tax Assets of $297.8 million for Q3 2010, up 12.9% from $263.7 million a year earlier but down 5.3% from the prior quarter.

Analysis

Eli Lilly (LLY) Current Deferred Tax Assets (2009 - 2010) Analysis & Trends

At the end of FY2009, Eli Lilly posted Current Deferred Tax Assets of $271 million.

  • Five-year quarterly Current Deferred Tax Assets spans a low of $263.7 million in Q3 2009 and a high of $314.4 million in Q2 2010.
  • Per Business Quant data, the three quarters before Q3 2010 came in at $314.4 million (Q2 2010), $275.2 million (Q1 2010) and $271 million (Q4 2009).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 297.80 Mn
Jun 30, 2010 314.40 Mn
Mar 31, 2010 275.20 Mn
Dec 31, 2009 271.00 Mn
Sep 30, 2009 263.70 Mn
Jun 30, 2009 290.60 Mn
Mar 31, 2009 72.10 Mn
API Access

Eli Lilly Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=LLY&period=max&api_key=YOUR_API_KEY